| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.08 |